We re-affirm our commitment to the values that AmCham stands for and that we share.
Kārlis Danēvičs, Board member, Head of Credits and Risk at SEB Banka
On June 6, representatives of the Precision Medicine sub-group had an online meeting with Lithuanian colleagues from the Innovative Pharmaceutical Industry Association (IFPA) to discuss the precision medicine development in Lithuania and Latvia. The goal of the session was to exchange information on the activities aimed at developing precision medicine in both countries.
We are very pleased to be part of AmCham and are looking forward to driving innovation forward in Latvia.
Mikko Fernström, General Manager, Biogen Latvia